Ectopic Pregnancy

Detailed Overview

Normal embryo transport through the fallopian tube is hindered due to functional or structural tubal abnormalities, often secondary to prior inflammation or surgery. The trophoblast invades the tubal wall, which lacks the thick decidual lining of the uterus. As the embryo grows, it stretches the thin tubal wall. The highly vascular tubal mucosa is compromised, leading to luminal bleeding, or the expanding sac causes tubal rupture, resulting in massive hemoperitoneum. This condition is the leading cause of maternal mortality in the first trimester.

Epidemiology & Demographics

Accounts for about 1.5-2.0% of all reported pregnancies. The incidence has increased slightly over the past decades, largely due to better diagnostics, rising maternal age, and increased prevalence of pelvic inflammatory disease (PID) and assisted reproductive technology (ART).

Etiological Mechanism

The primary etiology is altered tubal transport mechanisms. Damage to the ciliated epithelium of the fallopian tube prevents the fertilized egg from reaching the uterus, leading to premature implantation in the tubal wall.

Primary Causes

Pelvic Inflammatory Disease (Chlamydia trachomatis, Neisseria gonorrhoeae)

Prior Tubal Surgery (e.g., tubal ligation or reconstruction)

Endometriosis

Congenital Tubal Anomalies

• Previous Ectopic Pregnancy: Increases recurrence risk to approximately 10-15%.
• History of PID: Causes scarring and damage to tubal cilia.
• Smoking: Alters tubal motility and ciliary function.
• IVF/Assisted Reproductive Tech: Altered hormonal milieu and embryo transfer mechanics.

Impaired transport allows the blastocyst to hatch and implant in the fallopian tube wall. The invading syncytiotrophoblast erodes into maternal blood vessels. Unlike the uterus, the fallopian tube muscularis is too thin to accommodate the growing conceptus or the ensuing hemorrhage. Hemorrhage occurs between the gestational sac and the tubal wall, causing dissection. This can lead to tubal abortion (extrusion out the fimbriated end) or frank tubal rupture. Rupture releases blood rapidly into the peritoneal cavity, leading to shock.

Characteristic Clinical Presentation

• Abdominal/Pelvic Pain: Usually unilateral, sharp, and crampy. Pain can become diffuse if rupture occurs.
• Vaginal Bleeding: Often light, spotting, or intermittent, resulting from decidual sloughing due to low progesterone.
• Amenorrhea: Missed menses, typical of early pregnancy, though some may confuse abnormal bleeding for a period.
• Shoulder Tip Pain: Referred pain from phrenic nerve irritation due to diaphragmatic irritation by hemoperitoneum.

Physical Examination Signs

• Adnexal tenderness or palpable adnexal mass
• Cervical motion tenderness (Chandelier sign)
• Peritoneal signs (rebound, guarding) if ruptured
• Hypotension and tachycardia (signs of hypovolemic shock)

• Hemorrhagic Shock: Massive internal bleeding leading to cardiovascular collapse and death.
• Infertility: Loss or damage to the fallopian tube reduces future fertility.
• Recurrent Ectopic Pregnancy: Structural tubal disease typically affects both tubes.

Diagnostic Criteria & Guidelines

A positive serum quantitative beta-hCG plus transvaginal ultrasound showing an adnexal mass/empty uterus. If beta-hCG is above the discriminatory zone (typically >1,500 to 3,500 mIU/mL depending on the institution) and ultrasound shows an empty uterus, it is highly suspicious for ectopic pregnancy. Serial beta-hCG levels that fail to rise appropriately (at least 35-53% in 48 hours) also suggest abnormal pregnancy.

Differential Diagnosis

• Threatened, Incomplete, or Complete Abortion
• Ruptured Ovarian Cyst
• Ovarian Torsion
• Acute Appendicitis
• Pelvic Inflammatory Disease (PID)

Laboratory Tests & Biomarkers

• Serum Quantitative beta-hCG: Suboptimal rise (<35-53% increase over 48 hours) or plateau.
• Serum Progesterone: Often <5 ng/mL (values >20 ng/mL usually indicate a normal intrauterine pregnancy).
• Complete Blood Count (CBC): May show decreased hemoglobin/hematocrit if significant internal bleeding has occurred.

Imaging Modalities & Findings

• Transvaginal Ultrasound (TVUS):

• Unruptured Ectopic
  Intact tube, patient is hemodynamically stable. Amenable to medical therapy.
• Ruptured Ectopic
  Tube has burst, resulting in hemoperitoneum and hemodynamic instability. Surgical emergency.

Second-Line & Adjunctive Therapy

If Methotrexate fails (beta-hCG does not fall by >15% between days 4 and 7), a second dose of Methotrexate (50 mg/m² IM) may be administered, or surgical intervention is pursued.

Surgical & Procedural Management

Laparoscopic Salpingostomy (removing the ectopic tissue and preserving the tube) or Salpingectomy (removal of the affected tube). Salpingectomy is preferred if the tube is extensively damaged, the patient is hemodynamically unstable, or fertility is no longer desired. Emergent laparotomy is indicated for severe hemorrhagic shock.

Recommended Lifestyle Changes

• Avoid intercourse, heavy lifting, or strenuous activity until beta-hCG levels reach zero if managed medically, to prevent tubal rupture.
• Smoking cessation to decrease the risk of future ectopic pregnancies.

Patient Counseling & Advice

Inform the patient that an ectopic pregnancy cannot result in a live birth and carries a life-threatening risk if untreated. Advise that future pregnancies are possible, but there is a 10-15% recurrence risk. Any future pregnancy requires early TVUS (at 5-6 weeks) to confirm intrauterine location.

Follow-Up & Monitoring Schedule

If managed with Methotrexate, weekly serum beta-hCG draws are required until levels reach non-pregnant values (<5 mIU/mL). This can take up to 8 weeks. Administer Rh(D) immune globulin (e.g., RhoGAM 300 mcg IM) to Rh-negative, unsensitized women.

Preventive Strategies

Prompt diagnosis and treatment of STIs (chlamydia, gonorrhea) to prevent PID. Use of condoms reduces STI transmission.

With prompt diagnosis, maternal mortality is extremely rare (<0.1%). Successful treatment with Methotrexate occurs in 70-90% of appropriately selected cases. Subsequent intrauterine pregnancy rates are generally 50-80%.